2019
Multivariate spatiotemporal modeling of drug- and alcohol-poisoning deaths in New York City, 2009–2014
Ransome Y, Subramanian SV, Duncan DT, Vlahov D, Warren J. Multivariate spatiotemporal modeling of drug- and alcohol-poisoning deaths in New York City, 2009–2014. Spatial And Spatio-temporal Epidemiology 2019, 32: 100306. PMID: 32007280, PMCID: PMC9996640, DOI: 10.1016/j.sste.2019.100306.Peer-Reviewed Original ResearchConceptsDrug-poisoning deathsMultivariate Poisson regression modelCurrent public health problemPublic health problemZip codesDrug overdose deathsCo-occurring epidemicsPublic health plannersPoisson regression modelsHigh prevalenceOverdose deathsHealth problemsHealth plannersHeavy drinkingDeathDrugsOutcomesRegression modelsPredictorsNew York CityIndividual-level predictorsPrevalenceYork City
2004
Neighborhood education inequality and use of cigarettes, alcohol, and marijuana
Galea S, Ahern J, Vlahov D. Neighborhood education inequality and use of cigarettes, alcohol, and marijuana. Annals Of Epidemiology 2004, 14: 623. DOI: 10.1016/j.annepidem.2004.07.086.Peer-Reviewed Original ResearchSubstance useNeighborhood educationSeparate multivariable regression modelsMultivariable regression modelsUse of cigarettesUse of substancesHigh prevalencePublic health researchHealth behaviorsDial phone surveyIndividual-level covariatesNew York City neighborhoodsRisk behaviorsAdult residentsMean educationGreater likelihoodPotential roleHealth researchPhone surveyPublic healthMarijuanaPrevalenceDrinkingRegression modelsNew York City
2002
Drug Dependence among Young Recently Initiated Injection Drug Users
Arria A, Fuller C, Strathdee S, Latkin C, Vlahov D. Drug Dependence among Young Recently Initiated Injection Drug Users. Journal Of Drug Issues 2002, 32: 1089-1102. DOI: 10.1177/002204260203200405.Peer-Reviewed Original ResearchInjection drug usersDrug usersDrug dependenceYoung injection drug usersCurrent drug dependenceDSM-IV criteriaDrug treatmentDrug useSignificant associationSociodemographic characteristicsCommunity settingsMeet criteriaDrug abuseNational Household SurveyHeroinCocaineHigher proportionMalesAssociationHousehold surveyPrevalenceProportion
2001
Highly Active Antiretroviral Therapy Associated with Improved Anemia Among HIV-Infected Women
Semba R, Shah N, Klein R, Mayer K, Schuman P, Gardner L, Vlahov D. Highly Active Antiretroviral Therapy Associated with Improved Anemia Among HIV-Infected Women. AIDS Patient Care And STDs 2001, 15: 473-480. PMID: 11587633, DOI: 10.1089/108729101753145466.Peer-Reviewed Original ResearchConceptsPrevalence of anemiaAntiretroviral therapyHuman immunodeficiency virus (HIV) infectionActive antiretroviral therapyCombination antiretroviral therapyImmunodeficiency virus infectionHIV-positive womenYears of treatmentIncrease of hemoglobinImproved anemiaMulticenter cohortVirus infectionHAARTAnemiaHIVWomenTherapyLinear regression modelsPrevalenceTreatmentBaselineHemoglobinRegression modelsSignificant changesMonotherapyPrevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users
Latka M, Ahern J, Garfein R, Ouellet L, Kerndt P, Morse P, Farshy C, Jarlais D, Vlahov D. Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. Journal Of Substance Abuse 2001, 13: 73-88. PMID: 11547626, DOI: 10.1016/s0899-3289(01)00071-2.Peer-Reviewed Original ResearchConceptsCorrelates of chlamydiaInjection drug usersYoung adult injection drug usersDrug usersSexual debutAdult injection drug usersAfrican American raceRecent sexual behaviorCumulative incidenceIDU populationPrevalent infectionChlamydia prevalenceGonorrhea prevalenceIncidence rateAmerican raceStandardized questionnaireGonorrheaYounger ageChlamydiaLogistic regressionPrevalenceDisease prevalenceIncidenceWomenSexual behaviorImprovement of Anemia Among HIV-Infected Injection Drug Users Receiving Highly Active Antiretroviral Therapy
Semba R, Shah N, Vlahov D. Improvement of Anemia Among HIV-Infected Injection Drug Users Receiving Highly Active Antiretroviral Therapy. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 26: 315-319. DOI: 10.1097/00042560-200104010-00003.Peer-Reviewed Original Research
2000
The prevalence of homelessness among injection drug users with and without HIV infection
Song J, Safaeian M, Strathdee S, Vlahov D, Celentano D. The prevalence of homelessness among injection drug users with and without HIV infection. Journal Of Urban Health 2000, 77: 678-687. PMID: 11194310, PMCID: PMC3456762, DOI: 10.1007/bf02344031.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusInjection drug usersInjection drug useIndependent predictorsDrug usersDrug useActive injection drug useLongitudinal cohort studyCross-sectional studyHIV/AIDSCross-sectional investigationHIV seroconversionCohort studyHIV seroprevalenceHIV infectionPrevalence of homelessnessImmunodeficiency virusMale sexLogistic regressionPrevalenceParticipantsMore experiencePredictorsSeroconversionSerostatus
1999
Prevalence and Incidence of HIV Among Incarcerated and Reincarcerated Women in Rhode Island
Rich J, Dickinson B, Macalino G, Flanigan T, Towe C, Spaulding A, Vlahov D. Prevalence and Incidence of HIV Among Incarcerated and Reincarcerated Women in Rhode Island. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 22: 161-166. PMID: 10843530, DOI: 10.1097/00126334-199910010-00008.Peer-Reviewed Original ResearchConceptsSelf-reported injection drug useIncidence of HIVInitiation of treatmentInjection drug useCase-control studySeronegative womenRecent temporal trendsHIV testHIV infectionHIV-positiveHIV prevalenceNonwhite raceRisk factorsAnnual prevalenceMandatory HIVHigh riskControl studyDrug useSexual riskHIVWomenPrevalencePrior incarcerationIncidenceIncarcerated womenPrevalence and Incidence of HIV Among Incarcerated and Reincarcerated Women in Rhode Island
Rich J, Dickinson B, Macalino G, Flanigan T, Towe C, Spaulding A, Vlahov D. Prevalence and Incidence of HIV Among Incarcerated and Reincarcerated Women in Rhode Island. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 22: 161. DOI: 10.1097/00042560-199910010-00008.Peer-Reviewed Original ResearchSelf-reported injection drug useIncidence of HIVInitiation of treatmentInjection drug useCase-control studySeronegative womenRecent temporal trendsHIV testHIV infectionHIV-positiveHIV prevalenceNonwhite raceRisk factorsAnnual prevalenceMandatory HIVHigh riskControl studyDrug useSexual riskHIVWomenPrevalencePrior incarcerationIncidenceIncarcerated womenHIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old
Carneiro M, Fuller C, Doherty M, Vlahov D. HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug And Alcohol Dependence 1999, 54: 83-86. PMID: 10101620, DOI: 10.1016/s0376-8716(98)00142-2.Peer-Reviewed Original ResearchConceptsInjection drug usersInjection drug useRisk behaviorsDrug usersDrug useCross-sectional studyRates of HIVHigh-risk behaviorsAge of initiationHIV infectionHIV prevalenceFirst injectionWide age rangeAverage ageNew initiatesHygiene practicesAge rangeAgeRecruitment techniquesInjectionYearsHIVInitiationInfectionPrevalence
1997
Update on the Seroepidemiology of Human Immunodeficiency Virus in the United States Household Population
McQuillan G, Khare M, Karon* J, Schable† C, Vlahov‡ D. Update on the Seroepidemiology of Human Immunodeficiency Virus in the United States Household Population. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1997, 14: 355-357. PMID: 9111478, DOI: 10.1097/00042560-199704010-00008.Peer-Reviewed Original ResearchConceptsYears of ageHIV infectionBlack men 40Human immunodeficiency virusNutrition Examination SurveyThird National HealthEstimates of seroprevalenceAnalysis of nonresponseNHANES III estimateBlack womenUnited States household populationMen 40HIV prevalenceImmunodeficiency virusExamination SurveyOverall prevalenceNational HealthHigh riskIndividuals 18Drug useHIVInfectionConfidence intervalsHousehold populationPrevalence
1995
Identification of Human Immunodeficiency Virus Primary Isolates Resistant to Interferon-α and Correlation of Prevalence to Disease Progression
Kiinzi M, Farzadegan H, Margolick J, Vlahov D, Pitha P. Identification of Human Immunodeficiency Virus Primary Isolates Resistant to Interferon-α and Correlation of Prevalence to Disease Progression. The Journal Of Infectious Diseases 1995, 171: 822-828. PMID: 7706808, DOI: 10.1093/infdis/171.4.822.Peer-Reviewed Original ResearchConceptsCD4 cell numbersHIV infectionIFN-alphaLow CD4 cell numbersSerum IFN-alpha levelsHuman immunodeficiency virusIFN-alpha levelsEndogenous IFN-alphaAbsence of AIDSCourse of infectionCell numberCorrelation of prevalenceIFN-alpha 2Immunodeficiency virusDisease progressionPrimary isolatesCell tropismResistant variantsAlpha 2InfectionAIDSPrevalenceFavor survivalSequential analysisIsolatesFactors Associated with Initiation of Zidovudine in a Cohort of Injection Drug Users
Solomon L, Vlahov D, Astemborski J, Galai N, Graham N, Nelson K. Factors Associated with Initiation of Zidovudine in a Cohort of Injection Drug Users. Journal Of Drug Issues 1995, 25: 225-233. DOI: 10.1177/002204269502500115.Peer-Reviewed Original Research
1993
Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland
Vlahov D, Nelson K, Quinn T, Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. European Journal Of Epidemiology 1993, 9: 566-569. PMID: 8307145, DOI: 10.1007/bf00209538.Peer-Reviewed Original Research
1992
Sterile Needles: Human Immunodeficiency Virus in Diabetic Intravenous Drug Users-Reply
Nelson K, Vlahov D, Anthony J, Solomon L. Sterile Needles: Human Immunodeficiency Virus in Diabetic Intravenous Drug Users-Reply. JAMA 1992, 267: 1340-1341. DOI: 10.1001/jama.1992.03480100046022.Peer-Reviewed Original ResearchDrug injection equipmentHIV infectionHuman immunodeficiency virusInjection equipmentSafe injection practicesDrug injection paraphernaliaImmunodeficiency virusInjection paraphernaliaLow prevalenceInjection practicesDrug usersDiabeticsIVDUsLower ratesInfectionParaphernalia lawsSterile needleBehavioral strategiesPrevalence
1991
Prevalence of Antibody to HIV-1 Among Entrants to US Correctional Facilities
Vlahov D, Brewer T, Castro K, Narkunas J, Salive M, Ullrich J, Muñoz A. Prevalence of Antibody to HIV-1 Among Entrants to US Correctional Facilities. JAMA 1991, 265: 1129-1132. PMID: 1995998, DOI: 10.1001/jama.1991.03460090077036.Peer-Reviewed Original ResearchConceptsPrevalence of antibodiesHuman immunodeficiency virus type 1Immunodeficiency virus type 1HIV-1 prevalenceHIV-1 seroprevalenceAge 25 yearsVirus type 1US correctional facilitiesConsecutive malesHIV-1Older womenOlder menPrevention programsType 1Young womenPrevalenceWomenCorrectional systemYoung menMenSeroprevalenceAntibodiesProgram planningCorrectional facilities